Prostate Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: *The patients that the urology department chief physician judged an examination for 11C-Colin PET/CT to be necessary. *The patients who show PSA failure after the treatments. *The patients who underwent or will undergo pelvic MRI, chest/abdomen CT, bone scintigraphy. *The patients in good condition. *The patients who can understand study contents, and a written agreement is provided
Exclusion criteria
Exclusion criteria: *The patients who cannot keep face up position because of sharp pain in succession for around 30 minutes. *The patients with the extreme claustrophobia. *The patients whom the ADL which I become independent and can inspect is not kept. *The patients who a study person in charge is judged to be inappropriate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare diagnostic accuracy (ROC analysis, sensitivity, specificity, and accuracy) for diagnosing lymph node recurrence between 11C-choline PET/CT and chest/abdomen CT. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare diagnostic accuracy (ROC analysis, sensitivity, specificity, and accuracy) for diagnosing local recurrence and distant metastasis and clinical impact between 11C-choline PET/CT and chest/abdomen CT. | — |
Countries
Japan
Contacts
Hyogo College of Medicine Nuclear Medicine and PET Center